Arsenic trioxide induces cell cycle arrest and affects Trk receptor expression in human neuroblastoma SK-N-SH cells
Abstract Background Arsenic trioxide (As2O3), a drug that has been used in China for approximately two thousand years, induces cell death in a variety of cancer cell types, including neuroblastoma (NB). The tyrosine kinase receptor (Trk) family comprises three members, namely TrkA, TrkB and TrkC....
Guardado en:
Autores principales: | Xiong,Xilin, Li,Yang, Liu,Ling, Qi,Kai, Chen,Yueqin, Fang,Jianpei |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2018
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602018000100217 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Liposome-Coated Arsenic–Manganese Complex for Magnetic Resonance Imaging-Guided Synergistic Therapy Against Carcinoma
por: Jin Z, et al.
Publicado: (2021) -
A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system
por: Lu Y, et al.
Publicado: (2018) -
A combined miR-34a and arsenic trioxide nanodrug delivery system for synergistic inhibition of HCC progression after microwave ablation
por: Jian Hu, et al.
Publicado: (2021) -
Pulp-Capping with Mineral Trioxide Aggregate
por: Peycheva Kalina
Publicado: (2015) -
Induction of Root Development and Apical Closure in Permanent Mandibular Molar with Irreversible Pulpitis through Total Pulpotomy with Application of Mineral Trioxide Aggregate
por: Gomez,Felipe, et al.
Publicado: (2020)